DVA MEXC RealStocks
Own real DVA shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-13 21:52:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
DaVita Inc. (DVA) operates in the SERVICES-MISC HEALTH & ALLIED SERVICES, NEC sector and is listed on NYSE. The stock is currently priced at $174.52, with a market capitalization of $10.95B and a P/E ratio of 11.90. Over the past 52 weeks, its price has ranged from $101.00 to $247.49. This page covers its latest market performance, valuation, price trends and company information.
$10.95B | |
$175.06 | |
$176.59 | |
$172.38 | |
$174.07 | |
493.22K | |
707.89K | |
11.90 | |
$247.49 | |
$101.00 | |
-- | |
-- |
DaVita Inc. (DVA) is trading at $174.50 in after-hours trading as of 2026-11-13 21:10:00, down 0.01% ($0.02) from the regular-session close of $174.52.
After-hours trading shows how investors are pricing DVA after the regular session closes. The current after-hours price is near the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, DaVita Inc. (DVA) moved from $194.82 to $174.52, representing a decline of 10.42% ($20.30).
The stock traded between $172.38 and $196.20 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 622.73 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 50.2%
DVA is currently trading at $174.52, placing it 50.2% of the way from its 52-week low of $101.00 to its 52-week high of $247.49. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
| Industry | SERVICES-MISC HEALTH & ALLIED SERVICES, NEC |
| Employees | 78,000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of DaVita Inc. (DVA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to DVA, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between DVA shares and USD.
DVA Shares to USD
1.00 DVA shares = 174.518 USD
Calculations are estimates based on the latest available price and are for reference only.